文献速递药疹与重症皮肤不良反应皮肤感染

肺炎支原体诱导的Stevens-Johnson综合征/中毒性表皮坏死松解症:专科中心队列的病例对照分析

Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized center.
PubMed 文献 · J Am Acad Dermatol · 2021-04-26

该研究纳入2003—2016年单中心收治的180例SJS/TEN患者,比较6例肺炎支原体(MP)血清学阳性者与71例药物因果性评估(ALDEN)评分>5的药物诱导SJS/TEN对照。两组基线特征、疾病分类、体表面积及黏膜受累程度无显著差异,但MP组出院及1年随访死亡率均显著低于对照组。

要点

  • MP相关SJS/TEN与药物诱导者在基线特征和皮损范围上无显著差异。
  • MP组出院死亡率0% vs 对照组22.5%(P < .001)。
  • MP组1年随访死亡率0% vs 对照组32.4%(P = .002)。

核心结论

  • MP相关SJS/TEN与药物诱导SJS/TEN在基线特征、疾病分类、体表面积受累和黏膜受累程度上无显著差异。
  • MP组出院死亡率为0%,对照组为22.5%(P < .001);1年随访死亡率MP组为0%,对照组为32.4%(P = .002)。
  • 作者认为MP诱导SJS/TEN是否需独立分类尚需更大样本的前瞻性研究验证。

研究设计与样本

  • 单中心回顾性病例对照分析,纳入2003—2016年该中心收治的全部SJS/TEN患者,均按标准化方案治疗。
  • 180例SJS/TEN患者中6例MP血清学阳性,与71例ALDEN评分>5的药物诱导SJS/TEN患者作对照比较。

主要发现

  • 两组基线特征、疾病分类、受累体表面积及黏膜受累程度均无显著差异。
  • 出院死亡率:MP组0% vs 对照组22.5%(P < .001)。
  • 1年随访死亡率:MP组0% vs 对照组32.4%(P = .002)。

关键数值与推荐

  • MP血清学阳性定义为纳入暴露组的依据。
  • 对照组为存在高知名度药物且ALDEN评分>5的药物诱导SJS/TEN病例。

临床怎么用

  • 对SJS/TEN患者应检测肺炎支原体血清学,以识别MP相关病例。
  • MP相关SJS/TEN的死亡风险在本队列中低于药物诱导者,可辅助预后沟通。

局限性

  • 回顾性设计。
  • 样本量小(MP阳性仅6例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mycoplasma pneumoniae (MP) infection is associated with extrapulmonary complications such as Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). OBJECTIVE: We evaluated the differences in epidemiology, clinical characteristics, and disease outcomes between drug-induced and Mycoplasma-related SJS/TEN. METHODS: All patients with SJS/TEN admitted to our center between 2003 and 2016 inclusive were treated under a standardized protocol. Comparative analysis was made between patients who tested positive for MP versus a control group with negative MP serology in the presence of high-notoriety drugs defined by an algorithm for assessment of drug causality in epidermal necrolysis >5. RESULTS: Of 180 cases of SJS/TEN patients treated in our institution, 6 had positive MP serologies and were compared to a control group of 71 cases of drug-induced SJS/TEN with an algorithm for assessment of drug causality in epidermal necrolysis score of >5. There were no significant differences in baseline characteristics, disease classification, body surface area involved, and extent of mucosal involvement. We found significant differences in mortality rates between the Mycoplasma and control groups on discharge (0% vs 22.5%, P < .001) and at 1-year follow up (0% vs 32.4%, P = .002), respectively. LIMITATIONS: Retrospective design, small sample size. CONCLUSION: Although recent studies have shown that MP-induced SJS/TEN is morphologically different and deserves a separate classification system, this would need to be borne out in larger prospective studies.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Liew YCC, Choo KJL, Oh CC, et al. Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized center. J Am Acad Dermatol. 2021. PMID: 33915240. doi:10.1016/j.jaad.2021.04.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。